Enabling precision medicine with explainable AI and multi-omics data

The full promise of powerful medicines, such as immuno-therapies, is often unrealized due to highly variable patient responses and an incomplete understanding of the factors defining these responses. This results in a trial-and-error approach to treatment selection, often causing unnecessary patient suffering, poor outcomes, and massive healthcare costs. Scailyte directly confronts this critical healthcare and societal challenge, guided by two key principles: deep biological understanding and patient impact. Our integrated approach combines multiple data modalities and our cutting-edge AI into a translational research platform that yields impactful precision medicine products. As pioneers in single-cell data discovery since 2017, we have developed a pipeline of diagnostic and predictive biomarkers tackling some of the most pressing clinical and therapeutic hurdles, often in novel ways.